Search For "immune modulator"
Thyroid cancer treatment does not benefit from addition of immune modulato
Updated : 2 years, 6 months ago IST
According to the findings of a multicenter phase II clinical trial, treating people who have differentiated thyroid cancer (DTC), an advanced form of thyroid cancer that arises from thyroid follicular cells, with the targeted tyrosine kinase inhibitor (TKI) cediranib in addition to their tre
Read More
Adding immune modulator to targeted therapy does not improve thyroid cance
Updated : 2 years, 6 months ago IST
According to the findings of a multicenter phase II clinical trial, treating patients with differentiated thyroid cancer (DTC), an advanced form of thyroid cancer that arises from thyroid follicular cells, in addition to their treatment with the targeted tyrosine kinase inhibitor (TKI) cedir
Read More
Here's cancer immunotherapy solution to bring novel immuno-oncology d
Updated : 8 years, 6 months ago IST
New Delhi [India], July 24 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.
Read More
TRAC, Canada and MedGenome announce Cancer Immunotherapy solution to bring
Updated : 8 years, 6 months ago IST
New Delhi [India], July 22 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.
Read More
TRAC, MedGenome announce Cancer Immunotherapy solution
Updated : 8 years, 6 months ago IST
New Delhi [India], July 22 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.
Read More